Viridian Therapeutics (NASDAQ: VRDN)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Viridian Therapeutics (NASDAQ: VRDN) through any online brokerage.
The latest price target for Viridian Therapeutics (NASDAQ: VRDN) was reported by JMP Securities on Friday, March 11, 2022. The analyst firm set a price target for 31.00 expecting VRDN to rise to within 12 months (a possible 130.31% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Viridian Therapeutics (NASDAQ: VRDN) is $13.46 last updated May 23, 2022, 8:00 PM UTC.
There are no upcoming dividends for Viridian Therapeutics.
Viridian Therapeutics’s Q2 earnings are confirmed for Wednesday, August 10, 2022.
There is no upcoming split for Viridian Therapeutics.
Viridian Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.